查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
氯胺酮治療診所市場:不同治療，療法，介紹原，各國，各地區- 產業分析，市場規模，市場佔有率，2023-2030年預測
市場調查報告書
商品編碼
1320173

氯胺酮治療診所市場:不同治療，療法，介紹原，各國，各地區- 產業分析，市場規模，市場佔有率，2023-2030年預測

Ketamine Clinics Market with COVID-19 Impact Analysis, By Treatment, By Therapy, By Referral Source, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年氯胺酮治療診所市場規模將達到 87.045 億美元，2023 年至 2030 年複合年增長率為 11.3%

氯胺酮治療診所市場 - 市場動態：

研究和臨床試驗以及對氯胺酮不斷增長的需求推動市場成長

精神疾病的盛行率不斷上升，加上傳統治療的局限性，正在推動對氯胺酮等替代療法的需求。此外，隨著早期研究顯示出積極的結果，需要更多的臨床試驗和研究來確定氯胺酮治療心理健康問題的長期安全性和有效性。此外，隨著研究的發展，對氯胺酮作為治療選擇的看法和接受程度可能會改變。此外，隨著氯胺酮療法獲得認可，一些知名診所和精神科診所已開始將其納入其產品陣容。然而，氯胺酮治療的保險範圍可能會構成重大挑戰，這可能會限制預測期內氯胺酮治療診所的市場成長。

氯胺酮治療診所市場 - 主要見解：

  • 由於精神健康狀況的盛行率上升以及傳統治療的局限性，預計氯胺酮治療診所行業將以顯著的速度增長
  • 根據治療區隔，預計現場治療將在不久的將來佔最大的市場佔有率
  • 根據治療區隔，憂鬱症將在 2022 年成為主要類型
  • 按地區劃分，北美將成為 2022 年主要收入來源

氯胺酮治療診所市場 - 區隔分析：

全球氯胺酮治療診所市場根據治療、轉診來源和地區進行區隔。

市場依治療分為三類：焦慮、憂鬱、創傷後壓力症候群和其他。由於患有嚴重憂鬱症的成年人數量不斷增加，憂鬱症類別可能會佔最大的銷售佔有率。氯胺酮也因其治療憂鬱症的潛在用途而引起醫學界的關注。此外，氯胺酮治療診所正在成為為患有憂鬱症和其他情緒障礙的患者提供氯胺酮治療的專業中心。

市場分為兩類：線上治療和現場治療。在預測期內，現場治療將佔市場佔有率。對於精神疾病，氯胺酮治療接受度的提高促使了氯胺酮的擴張，進一步推動了該領域的成長。此外，諮商師、心理學家和精神科醫生等心理健康專業人員也為患者提供治療課程。

根據轉診來源，市場分為三類：初級保健醫生、網路廣告和心理健康專業人員。初級保健醫生預計將主導市場佔有率。PCP 適用於診斷和治療多種疾病，例如焦慮症和憂鬱症等精神健康障礙。此外，如果初級保健醫生認為氯胺酮治療可能有助於治療嚴重或難治性憂鬱症或其他心理健康問題；如果患者認為氯胺酮治療可能有助於治療難治性憂鬱症或其他心理健康問題，則可能會被送到氯胺酮治療診所。心理健康問題。這些因素可能會推動該領域的成長。

氯胺酮治療診所市場 - 地理洞察：

從地區來看，該市場遍佈北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些地區根據其開展業務的國家進一步區隔。

氯胺酮臨床市場 - 競爭格局：

由於持續的鴉片類藥物危機、心理健康意識的提高以及世界各地氯胺酮治療診所數量眾多等因素，該市場正在呈現顯著增長。此外，氯胺酮治療診所產業正專注於眾多策略，例如聯盟、新服務推出、併購和業務擴張，以擴大其全球市場佔有率。此外，隨著越來越多的提供者進入該領域，氯胺酮治療診所市場的競爭正在加劇。例如，2023 年 4 月，Mindbloom 宣布與 SHIFT 合作，為員工提供家庭氯胺酮治療作為福利。此外，該合作夥伴關係還將透過 Mindbloom 為所有 SHIFT 員工提供家庭氯胺酮治療，價格僅為正常價格的一小部分。

目錄

第1章 氯胺酮治療診所市場概要

  • 調查範圍
  • 市場估計年數

第2章 摘要整理

  • 市場明細
  • 競爭考察

第3章 氯胺酮治療診所主要的市場趨勢

  • 氯胺酮治療診所推動市場要素
  • 氯胺酮治療診所阻礙市場要素
  • 氯胺酮治療診所市場機會
  • 氯胺酮治療診所市場未來趨勢

第4章 氯胺酮治療診所產業調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法規結構的分析

第5章 氯胺酮治療診所市場:COVID-19影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析

第6章 氯胺酮治療診所市場形勢

  • 氯胺酮治療診所市場佔有率分析，2022年
  • 各主要製造商的明細資料
    • 現有企業的分析
    • 新興企業的分析

第7章 氯胺酮治療診所市場- 不同治療

  • 概要
    • 不同治療的市場區隔佔有率分析
    • 不安
    • 憂鬱症
    • PTSD
    • 其他

第8章 氯胺酮治療診所市場- 療法

  • 概要
    • 療法的市場區隔佔有率分析
    • 線上療法
    • 現場療法

第9章 氯胺酮治療診所市場- 介紹原

  • 概要
    • 介紹原的市場區隔佔有率分析
    • 基層護理醫生
    • 線上廣告
    • 心理健康專家

第10章 氯胺酮治療診所市場-各地區

  • 簡介
  • 北美
    • 概要
    • 美國
    • 加拿大
  • 歐洲
    • 概要
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區(APAC)
    • 概要
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 概要
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概要
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析- 氯胺酮治療診所產業

  • 競爭儀表板
  • 企業簡介
    • Arevipharma GmbH
    • Biotechnica Pharma Global(BPG)
    • NY Ketamine Infusions
    • Core One Labs
    • Johnson &Johnson
    • Pfizer
    • Field Trip Health and Wellness Ltd.
    • Save Minds
    • Ember
    • UQUIFA
    • Mindbloom
    • Ketamine Clinics
    • Vitalitas Denver Ketamine Clinic

第12章 分析師的全方位展望

Product Code: ANV1484

REPORT HIGHLIGHT

Ketamine clinics market size was valued at USD 8,704.5 Million in 2022, expanding at a CAGR of 11.3% from 2023 to 2030.

Ketamine clinics are defined as hospitals that engage in therapeutic purposes by administering ketamine, a dissociative anesthetic, and analgesic drug. Moreover, as a potential treatment ketamine has drawn interest for numerous mental health conditions, especially anxiety disorders, post-traumatic stress disorder (PTSD), and treatment-resistant depression. In line with this, ketamine has shown promise in offering quick relief, generally within hours, while traditional antidepressant medications may require weeks or months to show results. Furthermore, ketamine clinics traditionally provide intravenous (IV) ketamine infusions or, in other cases, other forms of ketamine administration, including oral lozenges and nasal sprays.

Ketamine Clinics Market- Market Dynamics:

Research & Clinical Trials and Increasing Demand Ketamine will boost the market growth

The increasing prevalence of mental health conditions coupled with limitations of traditional treatments, in turn; there has been a rising demand for alternative therapies such as ketamine. Moreover, with the positive outcomes in early studies, more clinical trials and investigation is required to determine the long-term safety and effectiveness of ketamine for the treatment of mental health concern. In addition, as research develops the view and acceptance of ketamine as a treatment option may shift. Furthermore, some established medical practices and mental health clinics have started including ketamine treatment as part of their product line, as ketamine therapy gains more recognition. However, insurance coverage for ketamine therapy can be a major challenge, which may restrain the ketamine clinic's market growth over the forecast period.

Ketamine Clinics Market- Key Insights:

  • As per the analysis shared by our research analyst, the ketamine clinics market is estimated to grow annually at a CAGR of around 11.3% over the forecast period (2023-2030)
  • The ketamine clinics industry is projected to grow at a significant rate due to the rising prevalence of mental health conditions and limitations of traditional treatments
  • Based on therapy segmentation, on-site therapy was predicted to show maximum market share in the near future
  • Based on treatment segmentation, depression was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Ketamine Clinics Market- Segmentation Analysis:

The global ketamine clinics market is segmented on the basis of treatment, therapy, referral source, and region.

The market is divided into three categories based on treatment: anxiety, depression, PTSD, and others. The depression segment is likely to possess the largest revenue share owing to the growing number of adults with severe major depression. Additionally, in the medical community ketamine has gained attention for its potential use in treating depression. Moreover, ketamine clinics have emerged as specialized centers that provide ketamine therapy for patients who have suffered from depression or other mood disorders.

The market is divided into two categories based on therapy: online therapy and on-site therapy. The on-site therapy segment is likely to possess the market share over the forecast period. For mental health disorders increasing acceptance of ketamine therapy is led to an expansion of ketamine, further driving the segment growth. Additionally, mental health professionals also provide therapy sessions for patients including counselors, psychologists, and psychiatrists.

The market is divided into three categories based on referral sources: primary care physicians, online advertising, and mental health professionals. The primary care physicians segment is expected to dominate the market share. PCPs are suitable to diagnose and treat numerous medical conditions, such as mental health disorders like anxiety and depression. Moreover, primary care physicians may send their patients to ketamine clinics when primary care physicians think ketamine therapy might be helpful for severe or treatment-resistant depression or other mental health concerns. Thereby such factors may propel the segment growth.

Ketamine Clinics Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Ketamine Clinics Market- Competitive Landscape:

The market is witnessing significant growth, driven by factors including the ongoing opioid crisis, rising mental health awareness, and a large number of ketamine clinics across the globe. Moreover, ketamine clinics industries are focusing on numerous strategies such as partnerships, launching new services, mergers & acquisitions, and expansions to expand their market presence worldwide. Furthermore, as more providers have entered the space the ketamine clinics market has become more competitive. For instance, in April 2023, Mindbloom announced a partnership with SHIFT to provide at-home ketamine therapy as a benefit to its employees. Additionally, through this partnership, all SHIFT employees will have access to at-home ketamine therapy for a fraction of the normal price through Mindbloom.

Recent Developments:

For instance, in January 2022, Delic Holdings Corp announced its subsidiary, Ketamine Wellness Centers (KWC), has officially expanded operations into Utah with the opening of its Salt Lake City location.

Key features of the study:

  • This proposed research study on ketamine clinics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the ketamine clinics market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for ketamine clinics market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the ketamine clinics market.
  • Impact of COVID-19 on ketamine clinics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on ketamine clinics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the ketamine clinics market, we have also included competitive landscape and key innovator analysis for the ketamine clinics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the ketamine clinics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global ketamine clinics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL KETAMINE CLINICS MARKET KEY PLAYERS

  • Arevipharma GmbH
  • Biotechnica Pharma Global (BPG)
  • NY Ketamine Infusions
  • Core One Labs
  • Johnson & Johnson
  • Pfizer
  • Field Trip Health and Wellness Ltd.
  • Save Minds
  • Ember
  • UQUIFA
  • Mindbloom
  • Ketamine Clinics
  • Vitalitas Denver Ketamine Clinic

GLOBAL KETAMINE CLINICS MARKET, BY TREATMENT

  • Anxiety
  • Depression
  • PTSD
  • Others

GLOBAL KETAMINE CLINICS MARKET, BY THERAPY

  • Online Therapy
  • On-Site Therapy

GLOBAL KETAMINE CLINICS MARKET, BY REFERRAL SOURCE

  • Primary Care Physicians
  • Online Advertising
  • Mental Health Professionals

GLOBAL KETAMINE CLINICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Ketamine Clinics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Ketamine Clinics Market Snippet by Treatment
    • 2.1.2. Ketamine Clinics Market Snippet by Therapy
    • 2.1.3. Ketamine Clinics Market Snippet by Referral Source
    • 2.1.4. Ketamine Clinics Market Snippet by Country
    • 2.1.5. Ketamine Clinics Market Snippet by Region
  • 2.2. Competitive Insights

3. Ketamine Clinics Key Market Trends

  • 3.1. Ketamine Clinics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Ketamine Clinics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Ketamine Clinics Market Opportunities
  • 3.4. Ketamine Clinics Market Future Trends

4. Ketamine Clinics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ketamine Clinics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ketamine Clinics Market Landscape

  • 6.1. Ketamine Clinics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Ketamine Clinics Market - By Treatment

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
    • 7.1.2. Anxiety
    • 7.1.3. Depression
    • 7.1.4. PTSD
    • 7.1.5. Others

8. Ketamine Clinics Market - By Therapy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy, 2022&2030 (%)
    • 8.1.2. Online Therapy
    • 8.1.3. On-Site Therapy

9. Ketamine Clinics Market - By Referral Source

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Referral Source, 2022&2030 (%)
    • 9.1.2. Primary Care Physicians
    • 9.1.3. Online Advertising
    • 9.1.4. Mental Health Professionals

10. Ketamine Clinics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Ketamine Clinics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Ketamine Clinics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Ketamine Clinics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Ketamine Clinics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Ketamine Clinics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Referral Source, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Ketamine Clinics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Arevipharma GmbH
    • 11.2.2. Biotechnica Pharma Global (BPG)
    • 11.2.3. NY Ketamine Infusions
    • 11.2.4. Core One Labs
    • 11.2.5. Johnson & Johnson
    • 11.2.6. Pfizer
    • 11.2.7. Field Trip Health and Wellness Ltd.
    • 11.2.8. Save Minds
    • 11.2.9. Ember
    • 11.2.10. UQUIFA
    • 11.2.11. Mindbloom
    • 11.2.12. Ketamine Clinics
    • 11.2.13. Vitalitas Denver Ketamine Clinic

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Ketamine Clinics Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Ketamine Clinics Market, by Treatment2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Therapy Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy
  • TABLE Global Ketamine Clinics Market, by Therapy2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Referral Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Referral Source
  • TABLE Global Ketamine Clinics Market, by Referral Source 2018-2030 (USD Million)
  • TABLE Ketamine Clinics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Ketamine Clinics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE North America Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE EuropeKetamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Europe Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Asia Pacific Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Latin America Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Therapy, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Ketamine Clinics Market, by Referral Source, 2018-2030 (USD Million)

List of Figures

  • FIGURE Ketamine Clinics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment segment market share analysis, 2022&2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Therapy segment market share analysis, 2022&2030
  • FIGURE Therapy segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Referral Source segment market share analysis, 2022&2030
  • FIGURE Referral Source segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Ketamine Clinics Market share and leading players, 2022
  • FIGURE Europe Ketamine Clinics Market share and leading players, 2022
  • FIGURE Asia Pacific Ketamine Clinics Market share and leading players, 2022
  • FIGURE Latin America Ketamine Clinics Market share and leading players, 2022
  • FIGURE Middle East and Africa Ketamine Clinics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Germany Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Ketamine Clinics Market share analysis by country, 2022
  • FIGURE India Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Brazil Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Ketamine Clinics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Ketamine Clinics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)